Cited by 33Metabolism, Diabetes, and CancerLipid metabolism and biosynthesisLipid metabolism and disorders

Activating transcription factor 3, glucolipid metabolism, and metabolic diseases

Open access
Hu, Shuwei, Zhao, Xiaojie, Li, Rui, Hu, Chencheng, Wu, Huijuan, Li, Jing, Zhang, Yanqiao, Xu, Yanyong·2023·Journal of Molecular Cell Biology

Abstract

Lipids and glucose exert many essential physiological functions, such as providing raw materials or energy for cellular biosynthesis, regulating cell signal transduction, and maintaining a constant body temperature. Dysregulation of lipid and glucose metabolism can lead to glucolipid metabolic disorders linked to various metabolic diseases, such as obesity, diabetes, and cardiovascular disease. Therefore, intervention in glucolipid metabolism is a key therapeutic strategy for the treatment of metabolic diseases. Activating transcription factor 3 (ATF3) is a transcription factor that acts as a hub of the cellular adaptive-response network and plays a pivotal role in the regulation of inflammation, apoptosis, DNA repair, and oncogenesis. Emerging evidence has illustrated the vital roles of ATF3 in glucolipid metabolism. ATF3 inhibits intestinal lipid absorption, enhances hepatic triglyceride hydrolysis and fatty acid oxidation, promotes macrophage reverse cholesterol transport, and attenuates the progression of western diet-induced nonalcoholic fatty liver disease and atherosclerosis. In addition to its role in lipid metabolism, ATF3 has also been identified as an important regulator of glucose metabolism. Here, we summarize the recent advances in the understanding of ATF3, mainly focusing on its role in glucose and lipid metabolism and potential therapeutic implications.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jmcb/mjac067

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hu, S., Zhao, X., Li, R., Hu, C., Wu, H., Li, J., Zhang, Y., & Xu, Y.
Affiliations
  • Northeast Ohio Medical University (US)
  • Shanghai Medical College of Fudan University (CN)
  • Capital Medical University (CN)
Corresponding author
  • Hu, Shuwei
  • Zhang, Yanqiao
  • Xu, Yanyong
Venue
Journal of Molecular Cell Biology
Published
2022-10
Volume
14
Issue
10
ISSN
  • 1674-2788 (ISSN-L)
  • 1759-4685
OpenAlex
W4310780158
Cited by
33
References
75
Citations by year
2026: 9 · 2025: 11 · 2024: 10 · 2023: 3
FWCI
1.96
Type
journal article
Language
en
Open access
Locations
  • Journal of Molecular Cell Biology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (32271218, 81670519)
  • Science and Technology Commission of Shanghai Municipality (22ZR1414300)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords
ATF3, glucolipid metabolism, glucose metabolism, lipid metabolism, metabolic disorders, obesity, diabetes mellitus, cardiovascular disease, intestinal lipid absorption, fatty acid oxidation, reverse cholesterol transport, macrophages, non-alcoholic fatty liver disease, atherosclerosis, Western diet, transcriptional regulation
MeSH terms
Glucose, Humans, Lipids, Liver, Metabolic Diseases, Lipid Metabolism, Activating Transcription Factor 3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review